The global Al in clinical trials market was valued at USD 1.9 billion in 2023, growing at a CAGR of 24.3% from 2024 to 2033. The market is expected to reach USD 16.7 billion by 2033. Artificial intelligence (AI) improves the quality and integrity of data from clinical trials by streamlining the administration and integration of vast and varied information from various sources. Furthermore, AI provides secure data sharing and analysis environments, facilitating collaboration between academics and businesses.
Quangcaox Vn
U888
23win
대밤 대밤
Navonax Green Energy
Go88 Me Uk
Ace58
Blepharoplasty Miami
Preventcovidu23
55win